Addus HomeCare Corporation $ADUS Position Reduced by First Trust Advisors LP

First Trust Advisors LP trimmed its stake in shares of Addus HomeCare Corporation (NASDAQ:ADUS) by 17.6% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,013 shares of the company’s stock after selling 6,424 shares during the quarter. First Trust Advisors LP’s holdings in Addus HomeCare were worth $2,811,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ADUS. Global Retirement Partners LLC raised its stake in shares of Addus HomeCare by 395.7% in the 4th quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after purchasing an additional 186 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the last quarter. Acumen Wealth Advisors LLC bought a new position in shares of Addus HomeCare during the fourth quarter worth about $29,000. Private Trust Co. NA grew its stake in Addus HomeCare by 65.5% in the fourth quarter. Private Trust Co. NA now owns 283 shares of the company’s stock worth $30,000 after purchasing an additional 112 shares in the last quarter. Finally, Arax Advisory Partners grew its stake in Addus HomeCare by 95.8% in the fourth quarter. Arax Advisory Partners now owns 280 shares of the company’s stock worth $30,000 after purchasing an additional 137 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Addus HomeCare

In related news, insider Heather Brianne Dixon sold 288 shares of the firm’s stock in a transaction that occurred on Monday, June 22nd. The stock was sold at an average price of $93.77, for a total value of $27,005.76. Following the sale, the insider owned 44,371 shares of the company’s stock, valued at approximately $4,160,668.67. This trade represents a 0.64% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 788 shares of company stock worth $73,506. 4.10% of the stock is currently owned by corporate insiders.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $118.78 on Friday. The company has a market cap of $2.22 billion, a PE ratio of 20.84, a P/E/G ratio of 1.57 and a beta of 0.87. Addus HomeCare Corporation has a fifty-two week low of $87.95 and a fifty-two week high of $124.43. The firm has a 50-day simple moving average of $103.52 and a 200 day simple moving average of $101.60. The company has a quick ratio of 1.83, a current ratio of 1.69 and a debt-to-equity ratio of 0.05.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, August 3rd. The company reported $1.73 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.70 by $0.03. Addus HomeCare had a net margin of 7.13% and a return on equity of 9.96%. The firm had revenue of $377.41 million for the quarter, compared to analysts’ expectations of $376.24 million. During the same quarter last year, the company posted $1.49 earnings per share. Addus HomeCare’s revenue was up 8.0% on a year-over-year basis. On average, sell-side analysts anticipate that Addus HomeCare Corporation will post 6.25 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on ADUS. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday, May 18th. Barclays increased their target price on Addus HomeCare from $92.00 to $96.00 and gave the stock an “underweight” rating in a report on Wednesday, July 8th. Citigroup reiterated a “market outperform” rating on shares of Addus HomeCare in a research report on Friday, July 24th. Royal Bank Of Canada upped their price target on Addus HomeCare from $130.00 to $134.00 and gave the company an “outperform” rating in a research report on Wednesday. Finally, Weiss Ratings raised Addus HomeCare from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $130.88.

Addus HomeCare Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.